Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
HKSE - Delayed Quote HKD

TIANYUAN HEALTH (0557.HK)

Compare
0.445
0.000
(0.00%)
At close: March 24 at 11:13:43 AM GMT+8
Currency in HKD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
45,230
45,230
54,216
94,588
56,340
Cost of Revenue
17,285
17,285
19,391
23,281
18,766
Gross Profit
27,945
27,945
34,825
71,307
37,574
Operating Expense
50,765
50,765
57,433
88,732
80,932
Operating Income
-22,820
-22,820
-22,608
-17,425
-43,358
Net Non Operating Interest Income Expense
-3,391
-3,391
-3,931
-4,480
-2,421
Pretax Income
-28,778
-28,778
-40,349
-19,063
-125,847
Tax Provision
-1,821
-1,821
--
--
-15,812
Net Income Common Stockholders
-15,484
-15,484
-29,036
-16,854
-65,101
Diluted NI Available to Com Stockholders
-15,484
-15,484
-29,036
-16,854
-65,101
Basic EPS
-0.04
-0.04
-0.07
-0.04
-0.16
Diluted EPS
-0.04
-0.04
-0.07
-0.04
-0.16
Basic Average Shares
398,980
398,980
398,980
398,980
398,980
Diluted Average Shares
398,980
398,980
398,980
398,980
398,980
Rent Expense Supplemental
161
--
--
--
--
Total Expenses
68,050
68,050
76,824
112,013
99,698
Net Income from Continuing & Discontinued Operation
-15,484
-15,484
-29,036
-16,854
-65,101
Normalized Income
-15,261.060
-15,261.060
-19,620
-16,074
11,785.439
Interest Income
152
152
28
7
116
Interest Expense
3,543
3,543
3,959
4,487
2,537
Net Interest Income
-3,391
-3,391
-3,931
-4,480
-2,421
EBIT
-25,235
-25,235
-36,390
-14,576
-123,310
EBITDA
-16,159
-16,159
-26,861
-2,707
-102,168
Reconciled Cost of Revenue
17,285
17,285
19,391
23,281
18,766
Reconciled Depreciation
9,076
9,076
9,529
11,869
21,142
Net Income from Continuing Operation Net Minority Interest
-15,484
-15,484
-29,036
-16,854
-65,101
Total Unusual Items Excluding Goodwill
-238
-238
-9,416
-780
-87,935
Total Unusual Items
-238
-238
-9,416
-780
-87,935
Normalized EBITDA
-15,921
-15,921
-17,445
-1,927
-14,233
Tax Rate for Calcs
0
0
--
--
0
Tax Effect of Unusual Items
-15.060
-15.060
--
--
-11,048.561
12/31/2020 - 10/24/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade